4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-009081
EVP, Chief Reg. Affairs acquired 5,650 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lewis Tanya · EVP, Chief Reg. Affairs
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 1 in the form | +5,650 | 6,189 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −5,650 | 5,650 | 16,950 | D |
Loading xslF345X03/doc4.xml…